Climate Influence on Physiotherapy in Multiple Sclerosis
NCT ID: NCT01057719
Last Updated: 2010-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2006-06-30
2008-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physical Function, Health and Employment for People With Multiple Sclerosis
NCT06110468
Multiple Sclerosis, Menstrual Cycle and Physical Acivity
NCT06105463
Neurodynamic Interventions for Multiple Sclerosis
NCT03595631
The Effect of Physical Activity Levels on Dysmenorrhea Severity, Menstrual Symptoms, and Functional and Emotional Status in Women Diagnosed With Multiple Sclerosis
NCT07011875
Norwegian Psychomotor Physiotherapy - The Effect on Quality of Life
NCT02282007
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Sixty patients with gait problems and without heat intolerance were included in a cross-over study. They were randomized to a 4-week inpatient physiotherapy based on the Bobath concept in Norway or Spain, with cross-over the year after. Data from five physical performance measures and six self-reported measures were collected at screening, baseline, after treatment and three and six months after both treatment-periods. Change over time within groups and comparisons of change between groups were analyzed by mixed models.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Physiotherapy in Spain
Daily inpatient physiotherapy for four weeks in a warm climate
Physiotherapy
Individual tailored physiotherapy according to the Bobath concept sixty minutes each working day for four weeks
Physiotherapy in Norway
Daily inpatient physiotherapy for four weeks in a cold climate
Physiotherapy
Individual tailored physiotherapy according to the Bobath concept sixty minutes each working day for four weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physiotherapy
Individual tailored physiotherapy according to the Bobath concept sixty minutes each working day for four weeks
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Multiple sclerosis according to the McDonald criteria
* Disability equivalent to Expanded Disability Status Score (EDSS) between 4.0 and 6.5 (both included)
* Prepared to and considered able to follow the protocol and to attend the planned visits during the whole study period.
* Given written informed consent
Exclusion Criteria
* Received treatment with glucocorticoids the last month prior to inclusion or start of treatment.
* Excessive fatigue or severe cognitive dysfunction related to MS that would preclude safe participation in the protocol.
* Suffered from major depression or any other psychiatric disorder that would preclude safe participation in the protocol.
* Heat intolerance.
* Other serious concomitant disease that could preclude safe participation in the protocol.
* Alcohol or drug abuse or consumption that could preclude participation according to the protocol and to attend the planned visits during the whole study period.
* Breastfeeding or pregnancy
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oslo University Hospital
OTHER
University Hospital, Akershus
OTHER
University of Bergen
OTHER
Haukeland University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Haukeland University Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tori Smedal, MSc
Role: PRINCIPAL_INVESTIGATOR
Haukeland University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Haukeland University Hospital
Bergen, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
012.06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.